Clinical Pharmacology, USMLE Step 1 - Full Vignette with Extended Explanations скачать в хорошем качестве

Clinical Pharmacology, USMLE Step 1 - Full Vignette with Extended Explanations

Chapters 00:00 - Case Presentation and Question 05:02 - Correct Answer Revealed and Explanation A 26-year-old pregnant woman at 22 weeks presents for routine prenatal care in February, reporting prior morning nausea, mild evening ankle swelling, and brief palpitations. Her history includes childhood kidney disease, ablated arrhythmia, atopic dermatitis, and polymyalgia rheumatica in remission. Exam reveals elevated blood pressure with 1+ ankle edema and no other concerning findings. Which clinical features in this scenario are important when choosing chronic blood pressure management in pregnancy, and what pharmacologic considerations are relevant for safe maternal and fetal outcomes? VIDEO INFO Category: Clinical Pharmacology, USMLE Step 1 Difficulty: Easy - Basic level - Suitable for medical students Question Type: Mechanism Case Type: Pregnant Patient Watch the video for explanation, or see the full explanation at: https://endlessmedical.academy/auth?h... QUESTION At a prenatal clinic in February, a 26-year-old woman (G1P0) at 22 weeks by ultrasound comes for routine care. She lives with her spouse, stopped using methamphetamine 4 years ago, and does not smoke or drink. She reports morning nausea that is now improved, mild ankle swelling in the evening, and occasional brief palpitations similar to what she had as a teenager. She denies headache, vision change, right upper quadrant pain, vaginal bleeding, dysuria, or shortness of breath.... OPTIONS A. Methyldopa is a central alpha-2 adrenergic agonist that reduces sympathetic outflow to lower blood pressure and is considered safe in pregnancy B. Lisinopril blocks angiotensin-converting enzyme, reduces angiotensin II and aldosterone, and is contraindicated during all trimesters C. Warfarin inhibits vitamin K epoxide reductase to block clotting factor carboxylation and readily crosses the placenta causing embryopathy D. Labetalol blocks peripheral alpha-1 and beta-1/beta-2 adrenergic receptors to reduce blood pressure in pregnancy Further reading: [1] Hypertension in pregnancy: diagnosis and management (NICE NG133) Authors: National Institute for Health and Care Excellence (NICE) NICE. Year: 2023. Type: Guideline. Educational value: Clarifies evidence-based management pathways and thresholds for intervention. Confidence of existence and relevancy: 100% Available at: https://www.nice.org.uk/guidance/NG133 [2] Pregnancy and Lactation Labeling Final Rule (PLLR) Authors: U.S. Food and Drug Administration U.S. Food and Drug Administration. Year: 2014. Type: Source. Educational value: Explains risk categories and labeling to interpret drug safety for maternal-fetal care. Confidence of existence and relevancy: 100% Available at: https://www.fda.gov/vaccines-blood-bi... Links to sources are provided for optional further reading only. The questions and explanations are independently authored and do not reproduce or adapt any specific third-party text or content. --------------------------------------------------- Our cases and questions come from the https://EndlessMedical.Academy quiz engine - multi-model platform. Each question and explanation is forged by consensus between multiple top AI models (i.e. Open AI GPT, Claude, Grok, etc.), with automated web searches for the latest research and verified references. Calculations (e.g. eGFR, dosages) are checked via code execution to eliminate errors, and all references are reviewed by several AIs to minimize hallucinations. Important note: This material is entirely AI-generated and has not been verified by human experts; despite stringent consensus checks, perfect accuracy cannot be guaranteed. Exercise caution - always corroborate the content with trusted references or qualified professionals, and never apply information from this content to patient care or clinical decisions without independent verification. Clinicians already rely on AI and online tools - myself included - so treat this content as an additional focused aid, not a replacement for proper medical education. Visit https://endlessmedical.academy for more AI-supported resources and cases. This material can not be treated as medical advice. May contain errors. --------------------------------------------------- #USMLE #USMLE USMLE(R) is a registered trademark of the National Board of Medical Examiners (NBME). USMLE(R) is a joint program of the Federation of State Medical Boards (FSMB) and the NBME. Neither organization endorses this publication. This publication and EndlessMedical LLC have no connection or association with the USMLE(R). USMLE(R) is a registered trademark of the National Board of Medical Examiners (NBME). USMLE(R) is a joint program of the Federation of State Medical Boards (FSMB) and the NBME. Neither organization endorses this publication. This publication and EndlessMedical LLC have no connection or association with the USMLE(R).